Intchains Group
ICG
BIGG DIGITAL ASSETS INC
BBKCF
NEPTUNE DIGITAL ASSETS CORP
NPPTF
Bitdeer Technologies
BTDR
FRMO CORP
FRMO
US Stock MarketDetailed Quotes
LXEO Lexeo Therapeutics
- 6.280
- +0.240+3.97%
Close Dec 20 16:00 ET
- 6.280
- 0.0000.00%
Post 16:20 ET
207.65MMarket Cap-2.40P/E (TTM)
6.340High5.810Low598.93KVolume5.910Open6.040Pre Close3.72MTurnover3.21%Turnover RatioLossP/E (Static)33.07MShares22.33052wk High1.49P/B117.05MFloat Cap5.77052wk Low--Dividend TTM18.64MShs Float22.330Historical High--Div YieldTTM8.78%Amplitude5.770Historical Low6.214Avg Price1Lot Size
About Lexeo Therapeutics Company
Lexeo Therapeutics, Inc. is a clinical stage genetic medicine company, which engages in the development of therapies for hereditary and acquired diseases. The firm focuses on the medication of genetically defined cardiovascular diseases and sub-group of Alzheimer’s disease. It offers LX2006 for the treatment of patients with Friedreich's ataxia, cardiomyopathy, and LX1001 for APOE4 homozygous patients with Alzheimer's disease. The company was founded by Ronald G. Crystal in February 2017 and is headquartered in New York, NY.
Company Profile
SymbolLXEO
Company NameLexeo Therapeutics
Listing DateNov 3, 2023
Issue Price11.00
Founded2017
CEOMr. Richard Nolan Townsend
MarketNASDAQ
Employees58
Fiscal Year Ends12-31
Address345 Park Avenue South,6th floor
CityNew York
ProvinceNew York
CountryUnited States of America
Zip Code10010
Phone1-212-547-9879
Websitehttp://www.lexeotx.com
Company Executives
- Name
- Position
- Salary
- Richard Nolan Townsend
- Director and Chief Executive Officer
- 1.74M
- Jenny R. Robertson, J.D.
- Chief Business and Legal Officer
- 1.30M
- Dr. Kyle Rasbach, PhD,Pharm.D.
- Chief Financial Officer and Principal Accounting Officer
- --
- Dr. Sandi See Tai, M.D.
- Chief Development Officer
- --
- Dr. Eric Adler, M.D.
- Chief Medical Officer and Head of Research
- 3.04M
- Dr. Steven Altschuler, M.D.
- Chairman of the Board
- 200.15K
- Tolga Tanguler
- Director
- --
- Dr. Brenda Cooperstone, M.D.
- Independent Director
- 529.14K
- Paula H.J. Cholmondeley
- Independent Director
- 406.61K
- Mette Kirstine Agger
- Independent Director
- 10.50K
- Reinaldo M. Diaz
- Independent Director
- 7.38K
- Tim Van Hauwermeiren, M. Sc.
- Independent Director
- --
Trending US Stocks
U.S. Crypto Concept Stocks U.S. Crypto Concept Stocks
Companies involved in the creation, trade, and services of digital forms of money.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S. Crypto Concept Stocks, ranked from highest to lowest based on real-time market data. Companies involved in the creation, trade, and services of digital forms of money.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S. Crypto Concept Stocks, ranked from highest to lowest based on real-time market data.